Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 510 | 5 | 26 | 295 | 72 |
| TOTAL | $514 | $5 | $26 | $295 | $72 |
| Non-Current Assets | |||||
| Intangibles | 145 | 134 | 113 | 76 | 47 |
| TOTAL | $145 | $134 | $113 | $76 | $47 |
| Total Assets | $659 | $139 | $139 | $371 | $119 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 48 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,893 | 667 | 330 | 1,464 | 1,155 |
| Other current liabilities | 502 | 411 | 1,015 | 39 | 0 |
| TOTAL | $3,250 | $1,931 | $3,244 | $3,668 | $3,278 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 13 | 90 | 193 | 496 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,250 | $1,931 | $3,244 | $3,668 | $3,278 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,362 | 88,882 | 166,493 | 123,502 | 110,841 |
| Common Shares | 108 | 87 | 145 | 123 | 111 |
| Retained earnings | -21,044 | -18,921 | -15,699 | -11,227 | -8,754 |
| Other shareholders' equity | 0 | 0 | -636 | -591 | -397 |
| TOTAL | $-2,591 | $-1,792 | $-3,105 | $-3,297 | $-3,158 |
| Total Liabilities And Equity | $659 | $139 | $139 | $371 | $119 |